Douglas Miehm
Stock Analyst at RBC Capital
(4.03)
# 1,693
Out of 4,520 analysts
390
Total ratings
51.3%
Success rate
5.7%
Average return
Main Sectors:
Stocks Rated by Douglas Miehm
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LGND Ligand Pharmaceuticals | Maintained: Buy | $262 → $340 | $303.39 | +12.07% | 17 | Jul 14, 2026 | |
| TSX: APTX Apotex Health Corp. | Initiated Coverage: Buy | $43.00 | $37.68 | +14.12% | 1 | Jul 6, 2026 | |
| TSX: DHT.UN DRI Healthcare Trust | Maintained: Buy | $21.00 | $18.14 | +15.77% | 41 | May 15, 2026 | |
| TSX: DR Medical Facilities Corporation | Maintained: Hold | $17.00 → $19.00 | $17.85 | +6.44% | 46 | May 10, 2026 | |
| TSX: WELL WELL Health Technologies Corp. | Reiterated: Buy | $7.00 | $4.19 | +67.06% | 22 | May 10, 2026 | |
| AUPH Aurinia Pharmaceuticals | Reiterated: Hold | $15 | $15.96 | -6.02% | 43 | May 8, 2026 | |
| TSX: GUD Knight Therapeutics Inc. | Maintained: Buy | $8.50 → $9.50 | $9.82 | -3.26% | 27 | May 8, 2026 | |
| MNKD MannKind | Maintained: Hold | $3.5 → $4.75 | $4.03 | +17.87% | 8 | May 7, 2026 | |
| PCRX Pacira BioSciences | Maintained: Hold | $22 → $24 | $25.61 | -6.29% | 5 | Apr 30, 2026 | |
| TSX: BHC Bausch Health Companies Inc. | Maintained: Hold | $12.62 | $6.78 | +86.19% | 102 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $16.26 | +29.15% | 36 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7.84 | $13.89 | -43.54% | 1 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.5 → $3.5 | $0.8533 | +310.17% | 30 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 → $19 | $4.30 | n/a | 2 | Oct 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €22.00 | €119.20 | n/a | 3 | Jun 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $6.27 | n/a | 6 | Aug 4, 2016 |
Ligand Pharmaceuticals
Jul 14, 2026
Maintained: Buy
Price Target: $262 → $340
Current: $303.39
Upside: +12.07%
Apotex Health Corp.
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $43.00
Current: $37.68
Upside: +14.12%
DRI Healthcare Trust
May 15, 2026
Maintained: Buy
Price Target: $21.00
Current: $18.14
Upside: +15.77%
Medical Facilities Corporation
May 10, 2026
Maintained: Hold
Price Target: $17.00 → $19.00
Current: $17.85
Upside: +6.44%
WELL Health Technologies Corp.
May 10, 2026
Reiterated: Buy
Price Target: $7.00
Current: $4.19
Upside: +67.06%
Aurinia Pharmaceuticals
May 8, 2026
Reiterated: Hold
Price Target: $15
Current: $15.96
Upside: -6.02%
Knight Therapeutics Inc.
May 8, 2026
Maintained: Buy
Price Target: $8.50 → $9.50
Current: $9.82
Upside: -3.26%
MannKind
May 7, 2026
Maintained: Hold
Price Target: $3.5 → $4.75
Current: $4.03
Upside: +17.87%
Pacira BioSciences
Apr 30, 2026
Maintained: Hold
Price Target: $22 → $24
Current: $25.61
Upside: -6.29%
Bausch Health Companies Inc.
Apr 30, 2026
Maintained: Hold
Price Target: $12.62
Current: $6.78
Upside: +86.19%
Apr 30, 2026
Maintained: Buy
Price Target: $21
Current: $16.26
Upside: +29.15%
Mar 19, 2026
Maintained: Buy
Price Target: $7.84
Current: $13.89
Upside: -43.54%
Nov 19, 2025
Maintained: Buy
Price Target: $2.5 → $3.5
Current: $0.8533
Upside: +310.17%
Oct 8, 2021
Reiterated: Hold
Price Target: $18 → $19
Current: $4.30
Upside: n/a
Jun 23, 2021
Maintained: Buy
Price Target: €22.00
Current: €119.20
Upside: n/a
Aug 4, 2016
Reiterated: Hold
Price Target: $1
Current: $6.27
Upside: n/a